| 000 | 01869 a2200529 4500 | ||
|---|---|---|---|
| 005 | 20250516094850.0 | ||
| 264 | 0 | _c20121217 | |
| 008 | 201212s 0 0 eng d | ||
| 022 | _a1538-8514 | ||
| 024 | 7 |
_a10.1158/1535-7163.MCT-11-0997 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBurris, Howard A | |
| 245 | 0 | 0 |
_aPhase I study of pazopanib in combination with paclitaxel and carboplatin given every 21 days in patients with advanced solid tumors. _h[electronic resource] |
| 260 |
_bMolecular cancer therapeutics _cAug 2012 |
||
| 300 |
_a1820-8 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial, Phase I; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAntineoplastic Combined Chemotherapy Protocols _xadverse effects |
| 650 | 0 | 4 |
_aCarboplatin _xadministration & dosage |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aIndazoles |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMaximum Tolerated Dose |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aNeoplasm Staging |
| 650 | 0 | 4 |
_aNeoplasms _xdrug therapy |
| 650 | 0 | 4 |
_aPaclitaxel _xadministration & dosage |
| 650 | 0 | 4 |
_aPyrimidines _xadministration & dosage |
| 650 | 0 | 4 |
_aSulfonamides _xadministration & dosage |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aDowlati, Afshin | |
| 700 | 1 | _aMoss, Rebecca A | |
| 700 | 1 | _aInfante, Jeffrey R | |
| 700 | 1 | _aJones, Suzanne F | |
| 700 | 1 | _aSpigel, David R | |
| 700 | 1 | _aLevinson, Kelly T | |
| 700 | 1 | _aLindquist, Diana | |
| 700 | 1 | _aGainer, Shelby D | |
| 700 | 1 | _aDar, Mohammed M | |
| 700 | 1 | _aSuttle, A Benjamin | |
| 700 | 1 | _aBall, Howard A | |
| 700 | 1 | _aTan, Antoinette R | |
| 773 | 0 |
_tMolecular cancer therapeutics _gvol. 11 _gno. 8 _gp. 1820-8 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1158/1535-7163.MCT-11-0997 _zAvailable from publisher's website |
| 999 |
_c21847856 _d21847856 |
||